Premier Fund Managers’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,769
| Closed | -$189K | – | 212 |
|
|
2024
Q2 | $189K | Hold |
6,769
| – | – | 0.01% | 190 |
|
|
2024
Q1 | $197K | Sell |
6,769
-117,764
| -95% | -$3.43M | 0.01% | 202 |
|
|
2023
Q4 | $4.18M | Sell |
124,533
-3,310
| -3% | -$111K | 0.18% | 87 |
|
|
2023
Q3 | $3.94M | Sell |
127,843
-23,434
| -15% | -$723K | 0.19% | 89 |
|
|
2023
Q2 | $5.98M | Buy |
+151,277
| New | +$5.98M | 0.24% | 78 |
|
|
2023
Q1 | – | Sell |
-46,971
| Closed | -$1.83M | – | 241 |
|
|
2022
Q4 | $1.83M | Buy |
46,971
+23,721
| +102% | +$924K | 0.07% | 144 |
|
|
2022
Q3 | $1.26M | Sell |
23,250
-141,000
| -86% | -$7.65M | 0.09% | 102 |
|
|
2022
Q2 | $9.63M | Sell |
164,250
-36,893
| -18% | -$2.16M | 0.43% | 66 |
|
|
2022
Q1 | $15.2M | Buy |
201,143
+25,450
| +14% | +$1.93M | 0.53% | 61 |
|
|
2021
Q4 | $10.7M | Sell |
175,693
-1,800
| -1% | -$110K | 0.34% | 81 |
|
|
2021
Q3 | $10.1M | Hold |
177,493
| – | – | 0.33% | 82 |
|
|
2021
Q2 | $10.8M | Buy |
177,493
+3,800
| +2% | +$231K | 0.36% | 72 |
|
|
2021
Q1 | $12.3M | Sell |
173,693
-30,637
| -15% | -$2.17M | 0.48% | 64 |
|
|
2020
Q4 | $12M | Buy |
204,330
+61,656
| +43% | +$3.62M | 0.52% | 59 |
|
|
2020
Q3 | $8.47M | Buy |
142,674
+91,074
| +177% | +$5.4M | 0.49% | 62 |
|
|
2020
Q2 | $2.71M | Buy |
+51,600
| New | +$2.71M | 0.17% | 116 |
|